Cited by 117Animal testing and alternativesAcademic Publishing and Open AccessResearch Data Management Practices

Never waste a good crisis: confronting reproducibility in translational research

Open access
Drucker, Daniel J.·2016·Cell Metabolism

Abstract

The lack of reproducibility of preclinical experimentation has implications for sustaining trust in and ensuring the viability and funding of the academic research enterprise. Here I identify problematic behaviors and practices and suggest solutions to enhance reproducibility in translational research.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2016.08.006

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The necessity for enhancement of result reproducibility in the life sciences has been identified and is gradually being internalized by researchers and institutions alike.

    “The necessity for enhancement of result reproducibility in the life sciences has been identified and is gradually being internalized by researchers and institutions alike (Prinz et al., 2011; Drucker, 2016).”

    From In Vitro research Reproducibility: Keeping up High Standards (2019) · cites this paper as Drucker, 2016

    The paper says reproducibility issues in basic science are now debated regularly and describes increasing recognition of the value of questioning results (Abstract; page unavailable). It clearly identifies a need for improvement, but its proposals for funding agencies and scientific meetings do not establish that researchers and institutions alike are gradually internalizing that need. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Research works printed but not linked: 53

  1. [4]4. Baker, D. ∙ Lidster, K. ∙ Sottomayor, A. ... Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studies PLoS Biol. 2014; 12:e1001756 Crossref Scopus (246) PubMed Google Scholar
  2. [5]5. Battaglia, M. ∙ Atkinson, M.A. The streetlight effect in type 1 diabetes Diabetes. 2015; 64:1081-1090 Crossref Scopus (58) PubMed Google Scholar
  3. [7]7. Begley, C.G. ∙ Ioannidis, J.P. Reproducibility in science: improving the standard for basic and preclinical research Circ. Res. 2015; 116:116-126 Crossref Scopus (750) PubMed Google Scholar
  4. [8]8. Bersell, K. ∙ Choudhury, S. ∙ Mollova, M. ... Moderate and high amounts of tamoxifen in αMHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death Dis. Model. Mech. 2013; 6:1459-1469 Crossref Scopus (116) PubMed Google Scholar
  5. [9]9. Beura, L.K. ∙ Hamilton, S.E. ∙ Bi, K. ... Normalizing the environment recapitulates adult human immune traits in laboratory mice Nature. 2016; 532:512-516 Crossref Scopus (767) PubMed Google Scholar
  6. [10]10. Bonner-Weir, S. ∙ In’t Veld, P.A. ∙ Weir, G.C. Reanalysis of study of pancreatic effects of incretin therapy: methodological deficiencies Diabetes Obes. Metab. 2014; 16:661-666 Crossref Scopus (43) PubMed Google Scholar
  7. [12]12. Brouwers, B. ∙ de Faudeur, G. ∙ Osipovich, A.B. ... Impaired islet function in commonly used transgenic mouse lines due to human growth hormone minigene expression Cell Metab. 2014; 20:979-990 Full Text Full Text (PDF) Scopus (137) PubMed Google Scholar
  8. [14]14. Claus, S.P. ∙ Tsang, T.M. ∙ Wang, Y. ... Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypes Mol. Syst. Biol. 2008; 4:219 Crossref Scopus (294) PubMed Google Scholar
  9. [16]16. Collins, F.S. ∙ Tabak, L.A. Policy: NIH plans to enhance reproducibility Nature. 2014; 505:612-613 Crossref Scopus (973) PubMed Google Scholar
  10. [17]17. Donath, M.Y. Targeting inflammation in the treatment of type 2 diabetes: time to start Nat. Rev. Drug Discov. 2014; 13:465-476 Crossref Scopus (578) PubMed Google Scholar
  11. [18]18. Donath, M.Y. Multiple benefits of targeting inflammation in the treatment of type 2 diabetes Diabetologia. 2016; 59:679-682 Crossref Scopus (88) PubMed Google Scholar
  12. [19]19. Drucker, D.J. Incretin-based therapy and the quest for sustained improvements in β-cell health Diabetes Care. 2011; 34:2133-2135 Crossref Scopus (20) PubMed Google Scholar
  13. [21]21. Drucker, D.J. Deciphering metabolic messages from the gut drives therapeutic innovation: the 2014 Banting Lecture Diabetes. 2015; 64:317-326 Crossref Scopus (64) PubMed Google Scholar
  14. [23]23. Drucker, D.J. ∙ Yusta, B. Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2 Annu. Rev. Physiol. 2014; 76:561-583 Crossref Scopus (243) PubMed Google Scholar
  15. [24]24. Egan, A.G. ∙ Blind, E. ∙ Dunder, K. ... Pancreatic safety of incretin-based drugs--FDA and EMA assessment N. Engl. J. Med. 2014; 370:794-797 Crossref Scopus (436) PubMed Google Scholar
  16. [25]25. Emambokus, N. ∙ Granger, A. The Elephant in the Room Cell Metab. 2015; 22:345 Full Text Full Text (PDF) Scopus (2) PubMed Google Scholar
  17. [26]26. Freedman, L.P. ∙ Gibson, M.C. ∙ Ethier, S.P. ... Reproducibility: changing the policies and culture of cell line authentication Nat. Methods. 2015; 12:493-497 Crossref Scopus (93) PubMed Google Scholar
  18. [27]27. Freedman, L.P. ∙ Gibson, M.C. ∙ Bradbury, A.R.M. ... [Letter to the Editor] The need for improved education and training in research antibody usage and validation practices Biotechniques. 2016; 61:16-18 Crossref Scopus (27) PubMed Google Scholar
  19. [28]28. Fuchsberger, C. ∙ Flannick, J. ∙ Teslovich, T.M. ... The genetic architecture of type 2 diabetes Nature. 2016; 536:41-47 Crossref Scopus (799) PubMed Google Scholar
  20. [30]30. Gore, A.C. Editorial: antibody validation requirements for articles published in endocrinology Endocrinology. 2013; 154:579-580 Crossref Scopus (35) PubMed Google Scholar
  21. [33]33. Harwood, Jr., H.J. ∙ Listrani, P. ∙ Wagner, J.D. Nonhuman primates and other animal models in diabetes research J. Diabetes Sci. Technol. 2012; 6:503-514 Crossref Scopus (61) PubMed Google Scholar
  22. [34]34. Heffner, C.S. ∙ Herbert Pratt, C. ∙ Babiuk, R.P. ... Supporting conditional mouse mutagenesis with a comprehensive cre characterization resource Nat. Commun. 2012; 3:1218 Crossref Scopus (170) PubMed Google Scholar
  23. [35]35. Hodge, R.J. ∙ Paulik, M.A. ∙ Walker, A. ... Weight and Glucose Reduction Observed with a Combination of Nutritional Agents in Rodent Models Does Not Translate to Humans in a Randomized Clinical Trial with Healthy Volunteers and Subjects with Type 2 Diabetes PLoS ONE. 2016; 11:e0153151 Google Scholar
  24. [36]36. Hrabě de Angelis, M. ∙ Nicholson, G. ∙ Selloum, M. ..., EUMODIC Consortium Analysis of mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics Nat. Genet. 2015; 47:969-978 Crossref Scopus (119) PubMed Google Scholar
  25. [37]37. Huh, W.J. ∙ Khurana, S.S. ∙ Geahlen, J.H. ... Tamoxifen induces rapid, reversible atrophy, and metaplasia in mouse stomach Gastroenterology. 2012; 142:21-24.e7 Full Text Full Text (PDF) Scopus (181) PubMed Google Scholar
  26. [38]38. Kayton, N.S. ∙ Poffenberger, G. ∙ Henske, J. ... Human islet preparations distributed for research exhibit a variety of insulin-secretory profiles Am. J. Physiol. Endocrinol. Metab. 2015; 308:E592-E602 Crossref Scopus (66) PubMed Google Scholar
  27. [40]40. Kilkenny, C. ∙ Browne, W.J. ∙ Cuthill, I.C. ... Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research PLoS Biol. 2010; 8:e1000412 Crossref Scopus (5443) PubMed Google Scholar
  28. [41]41. Koitabashi, N. ∙ Bedja, D. ∙ Zaiman, A.L. ... Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models Circ. Res. 2009; 105:12-15 Crossref Scopus (165) PubMed Google Scholar
  29. [43]43. Lee, J.Y. ∙ Ristow, M. ∙ Lin, X. ... RIP-Cre revisited, evidence for impairments of pancreatic beta-cell function J. Biol. Chem. 2006; 281:2649-2653 Crossref Scopus (210) PubMed Google Scholar
  30. [44]44. Libby, P. Murine “model” monotheism: an iconoclast at the altar of mouse Circ. Res. 2015; 117:921-925 Crossref Scopus (48) PubMed Google Scholar
  31. [45]45. Lim, G.E. ∙ Brubaker, P.L. Glucagon-Like Peptide 1 Secretion by the L-Cell: The View From Within Diabetes. 2006; 55:S70-S77 Crossref Scopus (175) PubMed Google Scholar
  32. [46]46. Lyon, J. ∙ Manning Fox, J.E. ∙ Spigelman, A.F. ... Research-Focused Isolation of Human Islets From Donors With and Without Diabetes at the Alberta Diabetes Institute IsletCore Endocrinology. 2016; 157:560-569 Crossref Scopus (89) PubMed Google Scholar
  33. [47]47. Macleod, M.R. ∙ Lawson McLean, A. ∙ Kyriakopoulou, A. ... Risk of Bias in Reports of In Vivo Research: A Focus for Improvement PLoS Biol. 2015; 13:e1002273 Crossref Scopus (219) PubMed Google Scholar
  34. [48]48. Magnuson, M.A. ∙ Osipovich, A.B. Pancreas-specific Cre driver lines and considerations for their prudent use Cell Metab. 2013; 18:9-20 Full Text Full Text (PDF) Scopus (153) PubMed Google Scholar
  35. [49]49. Mancini, A.D. ∙ Poitout, V. GPR40 agonists for the treatment of type 2 diabetes: life after ‘TAKing’ a hit Diabetes Obes. Metab. 2015; 17:622-629 Crossref Scopus (93) PubMed Google Scholar
  36. [50]50. McNutt, M. Journals unite for reproducibility Science. 2014; 346:679 Crossref Scopus (207) PubMed Google Scholar
  37. [51]51. Mekada, K. ∙ Abe, K. ∙ Murakami, A. ... Genetic differences among C57BL/6 substrains Exp. Anim. 2009; 58:141-149 Crossref Scopus (273) PubMed Google Scholar
  38. [53]53. Pais, R. ∙ Gribble, F.M. ∙ Reimann, F. Stimulation of incretin secreting cells Ther. Adv. Endocrinol. Metab. 2016; 7:24-42 Crossref Scopus (72) PubMed Google Scholar
  39. [55]55. Parnaud, G. ∙ Bosco, D. ∙ Berney, T. ... Proliferation of sorted human and rat beta cells Diabetologia. 2008; 51:91-100 Crossref Scopus (201) PubMed Google Scholar
  40. [57]57. Pyke, C. ∙ Knudsen, L.B. The glucagon-like peptide-1 receptor--or not? Endocrinology. 2013; 154:4-8 Crossref Scopus (132) PubMed Google Scholar
  41. [59]59. Rankin, M.M. ∙ Kushner, J.A. Adaptive beta-cell proliferation is severely restricted with advanced age Diabetes. 2009; 58:1365-1372 Crossref Scopus (276) PubMed Google Scholar
  42. [60]60. Ritter, K. ∙ Buning, C. ∙ Halland, N. ... G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges J. Med. Chem. 2016; 59:3579-3592 Crossref Scopus (105) PubMed Google Scholar
  43. [61]61. Rother, K.I. ∙ Spain, L.M. ∙ Wesley, R.A. ... Effects of exenatide alone and in combination with daclizumab on beta-cell function in long-standing type 1 diabetes Diabetes Care. 2009; 32:2251-2257 Crossref Scopus (111) PubMed Google Scholar
  44. [62]62. Schmidt-Supprian, M. ∙ Rajewsky, K. Vagaries of conditional gene targeting Nat. Immunol. 2007; 8:665-668 Crossref Scopus (351) PubMed Google Scholar
  45. [63]63. Scrocchi, L.A. ∙ Drucker, D.J. Effects of aging and a high fat diet on body weight and glucose control in glucagon-like peptide-1 receptor -/- mice Endocrinology. 1998; 139:3127-3132 Crossref Scopus (64) PubMed Google Scholar
  46. [64]64. Sigmund, C.D. Viewpoint: are studies in genetically altered mice out of control? Arterioscler. Thromb. Vasc. Biol. 2000; 20:1425-1429 Crossref Scopus (110) PubMed Google Scholar
  47. [65]65. Speakman, J.R. ∙ Keijer, J. Not so hot: Optimal housing temperatures for mice to mimic the thermal environment of humans Mol. Metab. 2012; 2:5-9 Full Text Full Text (PDF) Scopus (147) PubMed Google Scholar
  48. [67]67. Tian, X.Y. ∙ Ganeshan, K. ∙ Hong, C. ... Thermoneutral Housing Accelerates Metabolic Inflammation to Potentiate Atherosclerosis but Not Insulin Resistance Cell Metab. 2016; 23:165-178 Full Text Full Text (PDF) Scopus (114) PubMed Google Scholar
  49. [68]68. Tschen, S.I. ∙ Dhawan, S. ∙ Gurlo, T. ... Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice Diabetes. 2009; 58:1312-1320 Crossref Scopus (291) PubMed Google Scholar
  50. [69]69. Ussar, S. ∙ Griffin, N.W. ∙ Bezy, O. ... Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome Cell Metab. 2015; 22:516-530 Full Text Full Text (PDF) Scopus (419) PubMed Google Scholar
  51. [72]72. Wang, B. ∙ Chandrasekera, P.C. ∙ Pippin, J.J. Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes Curr. Diabetes Rev. 2014; 10:131-145 Crossref Scopus (375) PubMed Google Scholar
  52. [73]73. Wicksteed, B. ∙ Brissova, M. ∙ Yan, W. ... Conditional gene targeting in mouse pancreatic ß-Cells: analysis of ectopic Cre transgene expression in the brain Diabetes. 2010; 59:3090-3098 Crossref Scopus (270) PubMed Google Scholar
  53. [74]74. Woods, S.C. ∙ Begg, D.P. Food for Thought: Revisiting the Complexity of Food Intake Cell Metab. 2015; 22:348-351 Full Text Full Text (PDF) Scopus (12) PubMed Google Scholar

Cited by

Sorted by citations

Authors
Drucker, D. J.
Affiliations
Mount Sinai Hospital (CA)
Corresponding author
Drucker, Daniel J.
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2016-09
Volume
24
Issue
3
Pages
348-360
ISSN
1550-4131 (ISSN-L)
OpenAlex
W2518883904
Cited by
117
References
19
Citations by year
2026: 3 · 2025: 7 · 2024: 9 · 2023: 6 · 2022: 8 · 2021: 17 · 2020: 14 · 2019: 26 · 2018: 14 · 2017: 10 · 2016: 3
FWCI
23.84
Type
journal article
Language
en
Open access
Locations
  • Cell Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Funders
Canadian Institutes of Health Research
Topics
  • Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
  • Social Sciences › Decision Sciences › Information Systems and Management › Academic Publishing and Open Access
  • Physical Sciences › Computer Science › Information Systems › Research Data Management Practices
Keywords
reproducibility, translational research, preclinical research, research integrity, research misconduct, research funding, public trust in science, research practices
MeSH terms
Animals, Communication, Publishing, Reproducibility of Results, Models, Animal, Animal Experimentation, Biomedical Research, Mice, Translational Research, Biomedical, Research Report

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review